Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Barr Laboratory BRL -- Ignore unavailable to you. Want to Upgrade?

To: harkenman who wrote (134)	11/3/1998 10:37:00 AM
From: E. Graphs	Read Replies (3) \| Respond to of 207

harkenman, I believe the stock is undervalued and will continue to move up. My price targets are ~41 and then ~66. The stock had a decrease of short interest (as of 10/23/98) of 47%, and at that time the stock was at 30 3/4, so I don't think this advance is from short covering. The stock may also be tracking (poss leading) the DRG index, which is doing well. As long as the market in general continues to recover, BRL should do well. dbc.com askresearch.com There has been a lot of good news out on this company, and they have some excellent high quality generics coming to market. I can imagine huge future profits on their new birth control drug. A wonderful solution for a huge market of young adults. I trade on technicals, but I like to choose companies based on solid fundamentals. Regards, E. Graphs